Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 3531-3540 Newer>

The Motley Fool March 9, 2007 Brian Lawler	Progenics Gets Backed Up Progenics Pharmaceutics and drugmaker giant Wyeth announced a delay in one of their methylnaltrexone programs. Investors, take note.
The Motley Fool March 7, 2007 Brian Lawler	Encysive's Outback Adventures The pharmaceutical gains marketing approval for its lead compound in Australia. Investors, take note.
The Motley Fool March 7, 2007 Rich Duprey	Eisai Courts Danger The start of a patent-infringement trial sets the stage for the Japanese pharmaceutical's loss of protection on a major drug.
Pharmaceutical Executive March 1, 2007 Walter Armstrong	He's Just Being Frank Cephalon's Frank Baldino is going global with plans to corner cancer.
Pharmaceutical Executive March 1, 2007 Beth Herskovits	If I Ran Pfizer The industry is at a crossroads, and all eyes are on the world's largest drug maker. When Pfizer leads, others follow. So we asked: If you had that sort of influence, how would you steer Big Pharma?
Pharmaceutical Executive March 1, 2007 Jill Wechsler	Washington Report: Safety First FDA seeks to regain public trust by making drug-safety information more transparent - and to head off more stringent legislation in the process.
Pharmaceutical Executive March 1, 2007 Patrick Clinton	From the Editor: Incurable Eventually we're going to have lifestyle drugs, powerful ones that will make amazing differences in how we live.
Pharmaceutical Executive March 1, 2007 George Koroneos	Ad Stars Honoring the most innovative, creative, and thought-provoking pharmaceutical ads of 2006 - and the people who created them.
Pharmaceutical Executive March 1, 2007 Sarah Houlton	Global Report: Ready ... Set ... The European Parliament has launched a formal process for assessing therapies developed through stem-cell research. Ethical issues that have wrangled US regulators, though, still need attention.
Pharmaceutical Executive March 1, 2007	Thought Leader: Joseph Brindisi, Kyowa Pharmaceuticals For discovery shops like Kyowa Pharmaceutical, which rely on optimizing the value of compounds in development, managing the pipeline and patent life is a major concern.
<Older 3531-3540 Newer> Return to current articles.